Loading...
Images of Sarah Nanzigu
(0 from 0 )1
0
0
News
African Pharmacology Science Gateway
agenda.ct.infn.it
Tanzania, Bioanalysis. DMPK. 3, Makerere University, Jackson Mukonzo. Norah Mwebaza. Sarah Nanzigu. Muhammad Ntale. Uganda, Bioanalysis. DMPK.
PhD Defence | Examining the sustainability of Anti-retroviral ...chs.mak.ac.ug › events › phd-defence-examining-sustai...
chs.mak.ac.ug
Dr. Sarah Nanzigu, Department of Pharmacology, Makerere University. External examiner: Assoc. Prof Edgar Mugema Mulogo, Mbarara University of Science ...
Police under fire over Ingrid arrest - Daily Monitorwww.monitor.co.ug › News › National
www.monitor.co.ug
Independent Voice activist Sarah Nanzigu of Makerere University College of Health Sciences said: “Irrespective of whether the victim did or did ...
Network Profiles
LinkedIn: Sarah Nanzigu - Consultant - any clinical research | LinkedIn
View Sarah Nanzigu's profile on LinkedIn, the world's largest professional community. Sarah has 1 job listed on their profile. See the complete profile on ...
LinkedIn: Sarah Nanzigu | LinkedIn
View Sarah Nanzigu's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Sarah Nanzigu discover ...
Business Profiles
Researchgate: Sarah Nanzigu
Kampala, Uganda
Books & Literature
LIBRIS - HIV treatment outcomes in Uga...
libris.kb.se
LIBRIS titelinformation: HIV treatment outcomes in Uganda : the impact of baseline characteristics and variability in pharmacokinetics and pharmacogenetics of...
bokus.com: Sarah Nanzigu - Böcker | Bokus bokhandel
Köp böcker av Sarah Nanzigu:
authors:"Sarah Nanzigu" - Search | Paperity
paperity.org
Paperity: the 1st multidisciplinary aggregator of Open Access journals & papers. Free fulltext PDF articles from hundreds of disciplines, all in one place
Advances in HIV Treatment - Google Books Resultbooks.google.de › books
books.google.de
Introduction 3 Sarah Nanzigu, Francis Xavier Kasujja and Immaculate Nankya 2. HIV-1 Entry Inhibitors Joshua R. Sawyer, Charles S. Venuto and Gene D.
Related Documents
Sarah Nanzigu - Academia.edu
independent.academia.edu
Academia.edu is a place to share and follow research.
[PDF] African Pharmacology Science Gateway - Free Download PDF
documen.site
Download African Pharmacology Science Gateway...
EFFECT OF HIV SEVERITY ON PHARMACOKINETICS AND …
regist2.virology-education.com
CYP2B6 genotype but not Rifampicin co-administration explains variability in long term efavirenz clearance and plasma exposure Presenter: Dr. Sarah Nanzigu
HIV/AIDS Patients Display Lower Relative Bioavailability of Efavirenz...
www.proquest.com
Jackson K. Mukonzo,1,2 Sarah Nanzigu,1,2 Dinko Rekic,3 Paul Waako,2 Daniel Röshammar,4 Michael Ashton,3. Jasper Ogwal-Okeng,2 Lars L. Gustafsson1 ...
Scientific Publications
Effect of Efavirenz on Endogenous Progesterone NCBI - NIHwww.ncbi.nlm.nih.gov › pmc › articles › PMC
www.ncbi.nlm.nih.gov
... Coadministering Ethinylestradiol/Levonorgestrel. Grant Munkwase, Kuteesa R. Bisaso, [...], and Sarah Nanzigu. Additional article information ...
Antiretroviral concentration measurements as an additional tool to...
aidsrestherapy.biomedcentral.com
Sarah Nanzigu. Department of Public Health, University Hospital, University of Zurich, Zurich, Switzerland. Jan Fehr. Department of Clinical ...
Poor immunological recovery among severely immunosuppressed...
www.ncbi.nlm.nih.gov
Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans. Sarah Nanzigu,1,2 Ronald Kiguba,1 ...
Publications
Publications Authored by Sarah Nanzigu | PubFacts
www.pubfacts.com
Publications Authored by Sarah Nanzigu
Effect of Efavirenz on Endogenous Progesterone Concentrations and...
www.hindawi.com
Grant Munkwase, Kuteesa R. Bisaso, Othman Kakaire, and Sarah Nanzigu, “Effect of Efavirenz on Endogenous Progesterone Concentrations ...
Erratum to: HIV/AIDS patients display lower relative bioavailability...
link.springer.com
“Jackson K. Mukonzo and Sarah Nanzigu contributed equally to this work. This study was funded by Swedish International Development ...
CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments,...
www.pubfacts.com
PubFacts seeks to make the world's scientific research easy to locate, access, and collaborate on.
Miscellaneous
Sarah Nanzigu | LinkedIn
www.linkedin.com
View Sarah Nanzigu's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Sarah Nanzigu discover inside
A web-based survey of needs of information resources, research tools,...
slideplayer.com
Background Many African scientists trained in high-income countries Often technology transfer required for trained scientists to work at their African home...
Host Variabilities Influencing HIV/ART Outcomes - Sarah Nanzigu -...
www.exlibris.ch
Host Variabilities Influencing HIV/ART Outcomes de Sarah Nanzigu - English books - commander la livre de la catégorie Médecine sans frais de port et bon...
presented by Jaran Eriksen, project co-coordinator - ppt ...slideplayer.com › slide
slideplayer.com
5 Postdocs - status Name Topic Mentors Statu Sarah Nanzigu Compliance monitoring among children receiving AL for uncomplicated malaria ...
Avhandlingar.se: SARAH NANZIGU
www.avhandlingar.se
Avhandlingar om SARAH NANZIGU. Sök bland avhandlingar från svenska högskolor och universitet på Avhandlingar.se.
Science Gateways: needs, potentials and examples for Open Science in...
slideplayer.com
Needs I: ties between scientists within Africa Published scientific articles Few publications by African collaboration only
This project has received funding from the European Union’s Horizon...
slideplayer.com
... Eliford Ngaimisi TanzaniaBioanalysis DMPK 3Makerere UniversityJackson Mukonzo Norah Mwebaza Sarah Nanzigu Muhammad Ntale UgandaBioanalysis ...
Search results for " Sarah Nanzigu"
www.morebooks.de
Host Variabilities Influencing HIV/ART Outcomes. The role of Variations in Baseline Characteristics, Pharmacokinetics and Pharmacogenetics in HIV/ART ...
Advances in HIV Treatment: HIV Enzyme Kobo.comwww.kobo.com › Home › eBooks
www.kobo.com
... in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy. by Gene D. Morse, Gene D. Morse, Sarah Nanzigu. series Frontiers in HIV Research #1 ...
Antiretroviral concentration measurements as an additional tool to...
jhu.pure.elsevier.com
Allan Buzibye, Joseph Musaazi, Amrei Von Braun, Sarah Nanzigu, Christine Sekaggya-Wiltshire, Andrew Kambugu, Jan Fehr, Mohammed ...
CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments,...
www.semanticscholar.org
Jackson K. Mukonzo, Sarah Nanzigu, Paul J Waako, Jasper Ogwal-okeng, Lars L Gustafson, Eleni Aklillu; Published in Pharmacogenomics. Save. Cite.
Cited By KJIM :: Korean Journal of Internal Medicinewww.kjim.org › journal › CitedByRenew
www.kjim.org
Allan Buzibye, Joseph Musaazi, Amrei von Braun, Sarah Nanzigu, Christine Sekaggya-Wiltshire, Andrew Kambugu, Jan Fehr, Mohammed ...
Poor immunological recovery among severely immunosuppressed...
www.dovepress.com
Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans Sarah Nanzigu,1,2 Ronald Kiguba,1 Joseph Kabanda,3 ...
Frontiers in HIV Research:: volume 1 | Bentham Sciencewww.eurekaselect.com › ...
www.eurekaselect.com
Volume: 1. Advances in HIV Treatment. Editor(s): Gene D. Morse and Sarah Nanzigu. DOI: eISBN: , 2015
Frontiers in HIV Research:: volume 1 | Bentham Science
www.eurekaselect.com
Frontiers in HIV Research. Volume: 1. Advances in HIV Treatment. Editor(s): Gene D. Morse and Sarah Nanzigu. DOI:
Browse Journals by Subject :: Life Sciences - Bentham Science
www.benthamsciencepublisher.org
... Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy eISBN: ISBN: Edited by: Gene D. Morse, Sarah Nanzigu
HIV treatment outcomes in Uganda : the impact of baseline ...openarchive.ki.se › xmlui › handle
openarchive.ki.se
Mukonzo JK and Sarah Nanzigu, Rekic D, Waako P, Roshammar D, Ashton M, Ogwal-Okeng J, Gustafsson LL, Aklillu E. HIV/AIDS patients ...
Browse eBooks | BenthamScience
ip-208-109-178-178.ip.secureserver.net
By: Gene D. Morse and Sarah Nanzigu. US $ 39. Frontiers in Myocardia. By: Vasilios E. Papaioannou. US $ Frontiers in Nanomedicine. By: Maria Luisa ...
CYP2B6 genotype, but not rifampicin-based anti-TB iucat
iucat.iu.edu
Publication Type: Academic Journal; Abstract: Author(s): Jackson K Mukonzo [ sup.aff1] [sup.aff2], Sarah Nanzigu [sup.aff1] [sup.aff2], Paul Waako [sup.aff1], ...
Journals - One Health - Scibeywww.scibey.com › journals › one-health
www.scibey.com
Ritah Nakato, James K. Tumwine, Sarah Nanzigu, Sandra Naluyima, Allan Buzibye, Lodrick Alinayitwe, Carol Makoha, Jackson K. Mukonzo. Crossref logo icon ...
Related search requests for Sarah Nanzigu
| Allan Buzibye Joseph Musaazi |
People Forename "Sarah" (79052) Name "Nanzigu" (1) |
sorted by relevance / date